Min Luo
Impact in
- Nephrology top 5%
- Acute Kidney Injury Research
- Gastroenterology top 5%
- Gastroesophageal reflux and treatments
Papers in
-
- Acute Kidney Injury Research 5
- Gout, Hyperuricemia, Uric Acid 1
- Genetics 4
- Mesenchymal stem cell research 3
- Inflammatory Bowel Disease 2
- Co-authors
- Wei Cheng (4 shared papers)Yin Luo (1 shared paper)Fei Zhao (2 shared papers)Shaobin Duan (2 shared papers)Chengyuan Tang (1 shared paper)Mimi Tang (3 shared papers)Shao-Bin Duan (3 shared papers)Xuehong Wang (1 shared paper)
- Journals
- Scientific Reports (4 papers)BMC Cancer (1 paper)Chromatographia (1 paper)Head & Neck (1 paper)Clinical and Experimental Pharmacology and Physiology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Min Luo
35 papers receiving 498 citations
Peers
Comparison fields: 5 of 63
- Nephrology 128
- Gastroenterology 66
- Cancer Research 42
- Genetics 20
- Oncology 46
Countries citing papers authored by Min Luo
This map shows the geographic impact of Min Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Luo more than expected).
Fields of papers citing papers by Min Luo
This network shows the impact of papers produced by Min Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Luo. The network helps show where Min Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 67 | |
| 2 | 2018 | 55 | |
| 3 | 2020 | 40 | |
| 4 | 2014 | 30 | |
| 5 | 2022 | 29 | |
| 6 | 2017 | 28 | |
| 7 | 2022 | 28 | |
| 8 | 2018 | 25 | |
| 9 | 2019 | 25 | |
| 10 | 2020 | 23 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 17 | |
| 13 | 2014 | 13 | |
| 14 | 2017 | 12 | |
| 15 | 2017 | 12 | |
| 16 | 2017 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2018 | 10 | |
| 19 | A randomized study comparing the effectiveness of microwave ablation radioimmunotherapy and postoperative adjuvant chemoradiation in the treatment of non-small cell lung cancer. | 2016 | 8 |
| 20 | 2012 | 7 |
About Min Luo
Min Luo is a scholar working on Nephrology, Genetics, Complementary and alternative medicine, Otorhinolaryngology and Pathology and Forensic Medicine, having authored 36 papers that have together received 515 indexed citations. Recurring topics across this work include Acute Kidney Injury Research (5 papers), Mesenchymal stem cell research (3 papers), Head and Neck Cancer Studies (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Medicinal Plant Extracts Effects (2 papers), Pain Mechanisms and Treatments (2 papers), Inflammatory Bowel Disease (2 papers) and Gout, Hyperuricemia, Uric Acid (1 paper). The work is most often cited by research in Nephrology (128 citations), Gastroenterology (66 citations), Cancer Research (42 citations), Genetics (20 citations) and Oncology (46 citations). Min Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wei Cheng, Yin Luo, Fei Zhao, Shaobin Duan, Chengyuan Tang, Mimi Tang, Shao-Bin Duan, Xuehong Wang, Yuyong Tan and Hongyi Zhu. Their work appears in journals such as Scientific Reports, BMC Cancer, Chromatographia, Head & Neck and Clinical and Experimental Pharmacology and Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.